Group 1 - The core point of the announcement is that CPE has completed the sale of most of its shares in the company, resulting in CPE no longer being a major shareholder as of August 18, 2025 [1] - The exit of CPE is expected to significantly enhance the stability of the company's shareholder structure and release multiple positive effects, including a smoother exit for private equity fund shareholders and the introduction of diverse, high-quality long-term investors [1] - The optimization of the shareholding structure is anticipated to increase the proportion of circulating shares, thereby enhancing market liquidity [1] Group 2 - The company expresses gratitude to CPE for its strategic guidance during its development and successful market entry as an early investor [1] - Following the resignation of Mr. Hu and Mr. Geng, the board has appointed Mr. Gao and Ms. Yi as non-executive directors, effective from August 18, 2025 [2]
美丽田园医疗健康：主要股东CPE完成出售股份